en

PRODUCT DETAIL

Harvoni 90 mg/400 mg filmom obalené tablety

Code 2394B
MA number EU/1/14/958/001
Product Form: tbl flm 28x90 mg/400 mg (fľ.HDPE)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AP ?
J05AP51 Sofosbuvir a ledipasvir
Shelf life: 72
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 17.11.2014
SmPC + PL: European Medicines Agency's database
Dokument: DHPC Amiodaron_HARVONI_DAKLINZA+SOVALDI 28 4 2015.pdf  
Safety feature Yes
Data update: 04.08.2020
eu-flag.png sk-flag.png